Ранолазин и ЧКВ (чрезкожное коронарное вмешательство) - Идеальное партнерство

1. Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pec-toris of the European Society of Cardiology. Eur Heart J 2006; 27: 1341-1381. 2. Ischemic Heart Disease. New York: Churchill Livingstone Inc., 1995. 3. Coronary microvascular dys-function. N Engl J Med 2007; 356: 830-840. 4. Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management. Circulation 2010; 121: 2317-2325. 5. Coronary artery spasm: a 2009 update. Circulation 2009; 119: 2531-2534. 6. Nonatherosclerotic Ischemic Heart Disease. New York: Raven Press, 1988. 7. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med 1994; 330: 1782-1788. 8. Coronary blood flow and myocardial ischemia. In Fuster V, Alexander RW, O’Rourke RA. Hurst’s The Heart. New York: McGraw-Hill, 2004, pp. 1153-1172. 9. Diagnosis and treatment of coronary artery spasm. Cardiol Rev 1996; 1: 1-6. 10. Local coronary supersensi-tivity to diverse vasoconstrictive stimuli in patients with variant angina. Circulation 1986; 74: 1255-1265. 11. Autonomic changes associated with spon-taneous coronary spasm in patients with variant angina. J Am Coll Cardiol 1996; 28: 1249-1256. 12. Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina. Circulation 2002; 105: 1545-1547. 13. Episodic coronary artery vasospasm and hypertension develop in the absence...